Gelion plc

("Gelion" or the "Company")

Exercise of options and change to total voting rights

Gelion (AIM: GELN), the Anglo-Australian battery storage innovator, announces that certain employees and ex-employees have exercised options (the "Options") over 560,000 ordinary shares of 0.1 pence in the Company ("Ordinary Shares") under the Company's Existing Share Option Plan.

Application has been made for the 560,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on or around 14 December 2021.

Following Admission, the Company's issued share capital will consist of 107,023,839 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be  107,023,839. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Options have been exercised at the following prices per Ordinary Share:

CONTACTS

Notes to editors

Gelion (AIM: GELN) is a publicly listed company on the London Stock Exchange AIM market. It was founded as a spin-out from the University of Sydney in 2015 by Professor Thomas Maschmeyer, one of the world's leading chemists who was awarded the Australian Prime Minister's Prize for Innovation 2020.

Gelion is a global renewable-energy storage innovator. By designing leading-edge battery technology for stationary and mobile energy, the Company supports the transition to a sustainable economy while delivering value for customers and investors.

The batteries are also scalable, using lead-acid battery manufacturing technology, and the Company expects to develop megawatt-hour capacity for large-scale infrastructure, including for solar and wind farms.

In addition to investing in the growth of its zinc-bromide technology, the Company will use funding to develop its mobile energy division to enhance existing lithium-ion and lithium-sulfur battery technologies used in electric vehicles and the emerging market in electric aviation.

For the mobile market, Gelion's technology pipeline includes:

Using additive technology developed by its R&D team, which cooperates closely with scientists at the School of Chemistry and the University of Sydney Nano Institute, Gelion will develop and license additives for advanced lithium-silicon and lithium-sulfur technologies for ultra-high-density batteries to extend the cycle-life and safety of mobile energy storage.

Gelion also recently announced a partnership with Battery Energy Power Solutions in Sydney to manufacture and distribute its zinc-bromide batteries for the Australian market.

Gelion qualified for the LSE Green Economy Mark which recognises London-listed companies and funds that derive more than 50% of their revenues from products and services that are contributing the environmental objectives such as climate change mitigation and adaptation, waste and pollution reduction, and the circular economy.  

To find out more, please visit: www.gelion.com.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.